7
ADVISING ON THE UPPER LIMITS OF FOLIC ACID SUPPLEMENTATION
High doses of folic acid can hide signs of vitamin B
12
deficiency. They can also bring on
or accelerate neurological complications associated with B
12
deficiency (IOM, 1998). As
well, women who have low vitamin B
12
status are at higher risk for NTD (Van Allen and
McCourt, 2002; Ray et al, 2007; Molloy et al, 2009). The prevalence of vitamin B
12
deficiency in women of childbearing age is considered very low (IOM, 1998). However,
some studies suggest that more women in this life stage group may have low vitamin B
12
status than expected (Ray et al, 2008). Women who do not or infrequently consume
foods of animal origin and do not take a vitamin B
12
containing supplement are most
likely to have deficient or marginal vitamin B
12
status (Allen, 2009).
Emerging data also suggest there may be additional health risks associated with taking
folic acid, including the development of colon cancer when preneoplastic cells are
present (Kim, 2006; Ashokkumar et al, 2007; Smith et al, 2008). It is important that
health care professionals do not advise higher doses of folic acid than is recommended
in this document, unless duly warranted.
REFERENCES
Allen LH. 2009. How common is vitamin B-12 deficiency? 89(2):693S-6S. Epub 2008 Dec 30.
Antony AC. 2007. In utero physiology: role of folic acid in nutrient delivery and fetal development. Am J Clin
Nutr 85(suppl):598S-603S.
Ashokkumar B, Mohammed ZM, Vaziri ND, Said HM. 2007. Effect of folate oversupplementation on folate
uptake by human intestinal and renal epithelial cells. Am J Clin Nutr 86(1):159-166.
Bodnar LM, Tang G, Ness RB, Harger G, Roberts JM. 2006. Periconceptional multivitamin use reduces the
risk of preeclampsia. Am J Epidemiol 164(5):470-7.
Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, Botting B, Cocchi G, de Vigan
C, de Walle H, Feijoo M, Irgens LM, McDonnell B, Merlob P, Ritvanen A, Scarano G, Siffel C, Metneki J,
Stoll C, Smithells R, Goujard J. 2005. International retrospective cohort study of neural tube defects in
relation to folic acid recommendations: are the recommendations working? Br Med J 330(7491):571. Epub
2005 Feb 18.
Canada Gazette part II. 1998. Regulatory impact analysis statement, SOR/98-550. 132(24):3029-33.
Czeizel AE, Timar L, Sarkozi A. 1999. Dose-dependent effect of folic acid on the prevention of orofacial
clefts. Pediatrics 79(4):257-68.
Cziezel AE. 2004. The primary prevention of birth defects: multivitamins or folic acid? Int J Med Sci 1(1):50-
61.
De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, Evans JA, Van den Hof MC, Zimmer P,
Crowley M, Fernandez B, Lee NS, Niyonsenga T. 2007. Reduction of neural-tube defects after folic acid
fortification in Canada. N Engl J Med 357(2):135-42.
Eichholzer M, Tönz O, Zimmermann R. 2006. Folic acid: a public-health challenge. Lancet 367(9528):1352-
61.
Goh YI, Bollano E, Einarson TR, Koren G. 2006. Prenatal multivitamin supplementation and rates of
congenital anomalies: A meta-analysis. J Obstet Gynaecol Can 28(8):680-9.
Health Canada. 2008. Canadian Community Health Survey, Cycle 2.2, Nutrition (2004) - Nutrient Intakes
from Food, Volume 2. Cat.: H164-45/2-2008E-PDF.
Institute of Medicine. 1998. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate,
Vitamin B12, Pantothenic Acid, Biotin and Choline (Washington DC: National Academies Press).
Institute of Medicine. 2006. Dietary Reference Intakes – The essential guide to nutrient requirements
(Washington DC: National Academies Press).